These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2105541)

  • 21. Effects of ICRF-187 on the cardiac and renal toxicity of epirubicin in spontaneously hypertensive rats.
    Dardir M; Herman EH; Ferrans VJ
    Cancer Chemother Pharmacol; 1989; 23(5):269-75. PubMed ID: 2495862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187).
    Herman EH; Ferrans VJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3436-40. PubMed ID: 6790165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.
    Herman EH; Zhang J; Ferrans VJ
    Cancer Chemother Pharmacol; 1994; 35(2):93-100. PubMed ID: 7987999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of flunarizine on the delayed cardiotoxicity of doxorubicin in rats.
    Villani F; Galimberti M; Monti E; Piccinini F; Poggi P; Lanza E; Rozza A; Favalli L
    Pharmacol Res; 1991 Feb; 23(2):195-202. PubMed ID: 2062794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of doxorubicin-induced cardiotoxicity by recombinant interleukin-1 in hamsters. Doxorubicin cardiotoxicity and interleukin-1.
    Yoshida T; Okumura H; Kaya H; Okabe Y; Matano S; Ohtake S; Nakamura S; Matsuda T
    Biotherapy; 1993; 6(2):125-32. PubMed ID: 8398571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat.
    Cirillo R; Sacco G; Venturella S; Brightwell J; Giachetti A; Manzini S
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):100-8. PubMed ID: 10630739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cardiotoxic, nephrotoxic and neurotoxic effects of doxorubicin by ICRF-159.
    Tian Hu S; Brändle E; Zbinden G
    Pharmacology; 1983; 26(4):210-20. PubMed ID: 6844396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits.
    Herman EH; Ferrans VJ
    Cancer Chemother Pharmacol; 1986; 16(2):102-6. PubMed ID: 3081268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexrazoxane does not protect against doxorubicin-induced damage in young rats.
    Héon S; Bernier M; Servant N; Dostanic S; Wang C; Kirby GM; Alpert L; Chalifour LE
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H499-506. PubMed ID: 12714334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors.
    van Acker SA; Kramer K; Voest EE; Grimbergen JA; Zhang J; van der Vijgh WJ; Bast A
    Cancer Chemother Pharmacol; 1996; 38(1):95-101. PubMed ID: 8603459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiotoxicity of doxorubicin: effects of 21-aminosteroids.
    Falcone G; Filippelli W; Mazzarella B; Tufano R; Mastronardi P; Filippelli A; Berrino L; Rossi F
    Life Sci; 1998; 63(17):1525-32. PubMed ID: 9808063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.
    Speyer JL; Green MD; Kramer E; Rey M; Sanger J; Ward C; Dubin N; Ferrans V; Stecy P; Zeleniuch-Jacquotte A
    N Engl J Med; 1988 Sep; 319(12):745-52. PubMed ID: 3137469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits.
    Herman EH; Ferrans VJ; Jordan W; Ardalan B
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):85-97. PubMed ID: 6789416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity.
    Demirkaya E; Avci A; Kesik V; Karslioglu Y; Oztas E; Kismet E; Gokcay E; Durak I; Koseoglu V
    Can J Physiol Pharmacol; 2009 Aug; 87(8):633-40. PubMed ID: 19767888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiotoxicity induced by doxorubicin in vivo: protective activity of the spin trap alpha-phenyl-tert-butyl nitrone.
    Jotti A; Paracchini L; Perletti G; Piccinini F
    Pharmacol Res; 1992 Sep; 26(2):143-50. PubMed ID: 1409255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICRF 187.
    Hellmann K
    J Chemother; 1989 Dec; 1(6):355-8. PubMed ID: 2515259
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
    Baba H; Stephens LC; Strebel FR; Siddik ZH; Newman RA; Ohno S; Bull JM
    Cancer Res; 1991 Jul; 51(13):3568-77. PubMed ID: 1905199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig.
    Perkins WE; Schroeder RL; Carrano RA; Imondi AR
    Br J Cancer; 1982 Oct; 46(4):662-7. PubMed ID: 6814473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.